Compound 2038
Identifiers
- Canonical SMILES:
CC(C)n1cc(cn1)-c1ccc2N([C@@H](C)CN(C(=O)C3CC3)c2c1)C(C)=O
- IUPAC name:
1-[(2S)-4-cyclopropanecarbonyl-2-methyl-6-[1-(propan-2-yl)-1H-pyrazol-4-yl]-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one
- InChi:
InChI=1S/C21H26N4O2/c1-13(2)24-12-18(10-22-24)17-7-8-19-20(9-17)23(21(27)16-5-6-16)11-14(3)25(19)15(4)26/h7-10,12-14,16H,5-6,11H2,1-4H3/t14-/m0/s1
- InChiKey:
OCYHSSHUJWVLMA-AWEZNQCLSA-N
External links
![]() 118079652 |
![]() CHEMBL4206854 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 1 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| Bromodomain / Histone | 6.38 | cancer | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 366.21 g/mol | |||
| HBA | 6 | |||
| HBD | 0 | |||
| HBA + HBD | 6 | |||
| AlogP | 2.05 | |||
| TPSA | 58.44 | |||
| RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 1 | 0 | 0 |
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
|---|---|---|---|---|---|---|---|---|
| 10.1021/acsmedchemlett.7b00191 | compound 17 | BRD4 Q9ESU6 |
H33 P84243 |
Biochemical assay | alphascreen BRD4 | pIC50 (half maximal inhibitory concentration, -log10) | 6.38 | |
| 10.1021/acsmedchemlett.7b00191 | compound 17 | BRD4 Q9ESU6 |
H33 P84243 |
Cellular assay | cellular viability MV4-11 | MV4-11 | pIC50 (half maximal inhibitory concentration, -log10) | 6.24 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.4797 | 1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One | DB03475 | |
| 0.4737 | 4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID | DB07762 | |
| 0.4546 | Nefiracetam | DB13082 | |
| 0.4496 | Etidocaine | DB08987 | |
| 0.4472 | 4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE | DB08087 | |
| 0.4412 | Ropivacaine | DB00296 | |
| 0.4412 | Bupivacaine | DB00297 | |
| 0.4412 | Levobupivacaine | DB01002 | |
| 0.4405 | GI-181771X | DB12309 | |
| 0.4375 | Diampromide | DB01502 | |
| 0.4364 | Delparantag | DB12955 | |
| 0.4338 | Mepivacaine | DB00961 | |
| 0.4328 | GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE | DB07813 | |
| 0.4306 | PF-477736 | DB12611 | |
| 0.4302 | SB-705498 | DB11883 |




